FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Xcision Medical System Breast Cancer Radiotherapy Technology Scores FDA Clearance

Jan. 4, 2018
A A

Maryland-based Xcision Medical Systems achieved FDA 510(k) clearance for its noninvasive stereotactic radiation therapy system indicated for breast cancer treatment.

The GammaPod system features thousands of focused radiation beams and a vacuum-assisted cup for immobilizing the breast during a treatment procedure to preserve healthy tissue around the tumor.

About 60 percent of all cancer patients receive some form of radiotherapy.

View today's stories